Package Insert: Information for the Patient
Quentiax 300 mg Film-Coated Tablets
Read this package insert carefully before starting to take this medication because it contains important information for you.
Quentiaxcontains a substance called quetiapine. It belongs to a group of medications called antipsychotics. Quentiaxmay be used to treat several diseases, such as:
Your doctor maycontinue prescribing Quentiax even when you are feeling better.
Do not takeQuentiax
If you are unsure, consult your doctor or pharmacist before takingQuentiax.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quentiax if:
Inform your doctor immediately if after taking Quentiax you experience any of the following:
These disorders may be caused by this type of medicine.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase when you first start treatment, as all these medicines take time to work, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Severe cutaneous adverse reaction (SCAR)
Severe cutaneous adverse reactions (SCARs), which may put your life at risk or be fatal, have been reported very rarely with quetiapine treatment. These have manifested frequently by:
Stop using Quentiax if you develop these symptoms and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking Quentiax. You and your doctor should monitor your weight regularly.
Children and adolescents
Quentiax should not be used in children and adolescents under 18 years of age.
Other medicines and Quentiax
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Do not takeQuentiaxif you are taking any of the following medicines:
Inform your doctor if you are using any of the following medicines:
Before stopping any of your medicines, consult your doctor first.
Quentiax with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medicine.
You should not take Quentiax during pregnancy, unless you have consulted your doctor.
You should not useQuentiaxif you are breastfeeding.
The following symptoms that may represent withdrawal syndrome may occur in newborn babies, of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, breathing problems, and feeding difficulties. If your baby experiences any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
Quentiaxmay cause symptoms such as drowsiness, dizziness, or visual disturbances, and may decrease your reaction time. These effects, as well as the underlying illness, may impair your ability to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention, until your doctor assesses your response to this medicine.
Quentiax contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmolof sodium (23 mg) per tablet; it is essentially "sodium-free".
Effect on Drug Detection Tests in Urine
If you are having a drug detection test in urine, taking Quentiax may produce positive results for methadone or certain antidepressant medicines called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and your needs, but it will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quentiax should not be used in children and adolescents under 18 years of age.
If you take more Quentiax than you should
If you take more Quentiax than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your Quentiax tablets with you.
You can also call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Quentiax
If you forget to take Quentiax, take your corresponding dose as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Quentiax
If you stop taking Quentiax abruptly, you may be unable to sleep (insomnia) or may feel nausea or may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before interrupting treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicinecan cause side effects, although not everyone will experience them.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect 1 in 100 people):
Rare side effects(may affect 1 in 1,000 people):
Very rare side effects(may affect 1 in 10,000 people):
Frequency not known(the frequency cannot be estimated from the available data):
The class of medicines to whichQuentiaxbelongs may cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effectsthat may occurin adultsmay also occur inchildren and adolescents.
The following side effects have been observed more frequentlyin children and adolescentsor have not been observed in adults.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medicationafter the expiration date indicated on the carton, container, and blister pack after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacist how to dispose of packaging and medications you no longer need. This will help protect the environment.
Composition of Quentiax
The active ingredient is quetiapine. Each film-coated tablet contains 300 mg of quetiapine (as quetiapine hemifumarate).
The other components are:
Core tablet: lactose monohydrate (lactose), calcium dihydrate phosphate, microcrystalline cellulose, povidone, sodium carboxymethyl starch (type A) from potato (potato starch), magnesium stearate.
Film coating: hypromellose, titanium dioxide (E171), macrogol 4000. See section 2 “Quentiax contains lactose and sodium”.
Appearance of the product and contents of the pack
The 300 mg film-coated tablets are capsule-shaped and white.
They are presented in Aluminio/PVC blisters of 60 tablets per pack.
Only some pack sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Responsible manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Or
KRKA - FARMA d.o.o., V. Holjevca 20/E, 10450 Jastrebarsko, Croatia
For further information about this medicinal product, please contact the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/Anabel segura 10, 28108 Alcobendas, Madrid, Spain
This medicinal product is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland)with the following names:
Member state name | Medicinal product name |
Austria, Denmark, Iceland, Sweden | Quetiapin Krka |
Belgium, France, Netherlands, Norway | Quetiapine Krka |
Bulgaria, Czech Republic, Estonia, Latvia, Lithuania, Poland, Romania, Slovakia | Kventiax |
Spain | Quentiax film-coated tablets EFG |
Greece | Quetiapine TAD |
Portugal | Quetiapina Krka |
Germany, Italy, Spain | Quentiax |
United Kingdom (Northern Ireland) | Quetiapine |
Last review date of this leaflet: December 2021
For detailed information about this medicinal product, please visit the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.